Skip to content
2000
Volume 16, Issue 10
  • ISSN: 1871-5273
  • E-ISSN: 1996-3181

Abstract

Background & Objective: Gliomas constitute 81% of malignant brain tumors and exhibit a poor prognosis. Two main events involved in the progression of gliomas are the deregulation of genes via genetic events and the cellular damage resulting from the formation of reactive oxygen species (ROS). In gliomas, epigenetic abnormalities implicated in the deregulation of deoxyribonucleic acid (DNA) methylation, nucleosome rearrangement, and acetylation of histones, have been depicted. The overproduction of ROS has been implicated in the promotion of these modifications. Conclusion: In this review, we discuss the epigenetic mechanisms and oxidative events that impact gene silencing and its association with the establishment and development of gliomas. Some of these epigenetic marks, or their related proteins, are under investigation for their potential use as biomarkers in clinical trials to propose personalized therapies for patients with glioblastoma.

Loading

Article metrics loading...

/content/journals/cnsnddt/10.2174/1871527317666180110124645
2017-12-01
2025-10-31
Loading full text...

Full text loading...

/content/journals/cnsnddt/10.2174/1871527317666180110124645
Loading

  • Article Type:
    Review Article
Keyword(s): Brain tumors; clinical trials; epigenetics; glioma; malignant; oxidative stress
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test